SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML [Comirnaty 2026-2027]

RxNorm concept 2751896, branded drug component (sbdc).

RxCUI: 2751896
Term type: Branded drug component (SBDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2751896 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein 2468231

Related concepts

0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML Prefilled Syringe [Comirnaty 2026-2027] (SBD, constitutes)
Comirnaty 2026-2027 (BN, has ingredient)
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML (SCDC, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2751896 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2751896 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2751896. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.